Topigen
About UsScienceInvestorsMedia CenterContact Us

MEDIA CENTER

Press Releases ◄
Past Events ◄




   ►Home    ►Site Index

Media Center

PRESS RELEASES (2006 Archives)


2006-11-28

TOPIGEN'S PRESIDENT AND CEO TO PRESENT AT BMO CAPITAL MARKETS' FOCUS ON HEALTHCARE CONFERENCE

2006-09-18

TOPIGEN BEGINS IND-ENABLING STUDIES FOR TPI 1100 THE FIRST RNA-TARGETING COMPOUND TO TREAT COPD

2006-07-18

TOPIGEN REPORTS POSITIVE THERAPEUTIC RESULTS FROM INITIAL PHASE II TRIAL STUDYING INHALED TPI ASM8

2006-05-23

TOPIGEN INITIATES PHASE II PROGRAM OF TPI 1020 IN RESPIRATORY DISORDERS

2006-05-16

TOPIGEN ANNOUNCES PRECLINICAL DATA AND ACCEPTANCE TO PRESENT AT THE AMERICAN THORACIC SOCIETY CONFERENCE

2006-04-19

TOPIGEN SECURES US$6.0MM FINANCING FROM MMV FINANCIAL INC. - ADDITIONAL FUNDING TO ADVANCE RESPIRATORY PRODUCT PIPELINE

2006-04-07

TOPIGEN’S CEO TO PRESENT AT BIO 2006 ANNUAL CHICAGO INTERNATIONAL CONVENTION BUSINESS FORUM

2006-04-03

DR. MITCHELL GLASS JOINS TOPIGEN’S SCIENTIFIC ADVISORY BOARD

2006-03-09

TOPIGEN CEO TO PRESENT AT SACHS ASSOCIATES 5TH ANNUAL NORTH AMERICAN FORUM

2006-02-09

TOPIGEN’S CEO TO PRESENT AT BIO CEO & INVESTOR CONFERENCE

2008
Archives 2007
Archives 2005

 

footer_line
Copyright © 2005-2008, Topigen Pharmaceuticals Inc.
All rights reserved. Terms of Use.